References
- Baker LA, Allis CD, Wang GG. PHD fingers in human diseases: disorders arising from misinterpreting epigenetic marks. Mutat Res 2008;647:3–12.
- Gécz J, Turner G, Nelson J, . The Börjeson–Forssman–Lehman syndrome (BFLS, MIM #301900). Eur J Hum Genet 2006;14:1233–1237.
- Van Vlierberghe P, Palomero T, Khiabanian H, . PHF6 mutations in T-cell acute lymphoblastic leukemia. Nat Genet 2010;42:338–342.
- Wang Q, Qiu H, Jiang H, . Mutation of PHF6 is associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia. Haematologica 2011;96: 1808–1814.
- Van Vlierberghe P, Patel J, Abdel-Wahab O, . PHF6 mutations in adult acute myeloid leukemia. Leukemia 2011;25:130–134.
- Patel JP, Gönen M, Figueroa ME, . Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med 2012;366:1079–1089.
- Radich JP. The biology of CML blast crisis. Hematology Am Soc Hematol Educ Program 2007:384–391.
- Güran S, Bahçe M, Beyan C, . P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia. Haematologia (Budap) 1998;29:181–193.
- Grossmann V, Kohlmann A, Zenger M, . A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases. Leukemia 2011;25:557–560.
- Zhang SJ, Ma LY, Huang QH, . Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Proc Natl Acad Sci USA 2008;105:2076–2081.
- Makishima H, Jankowska AM, McDevitt MA, . CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia. Blood 2011;117:e198–e206.